Metabolism Assays Market Size, Share & Trends by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028
Metabolism Assays Market Size, Share & Trends
The size of global metabolism assays market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
The growth in this market is attributed to the growing prevalence of diabetes, the global increase in the number of hospitals, and the high rate of obese population. However, alternative methods or techniques restrain the growth of this market.
Metabolism Assays Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Metabolism Assays Market Dynamics
DRIVER: Increasing funding and investments in metabolic research
Metabolic research funding and investments are crucial for advancing the metabolic processes understanding, producing new metabolic disease treatments, and improving public health. Diseases like diabetes, obesity, lipid metabolism, mitochondrial disorders, and metabolic pathways are being considered as metabolic diseases. Various sources, including government agencies, private foundations, pharmaceutical companies, and academic institutions are the sources for funding. For instance, clinical-stage biotechnology firm Eccogene raised USD 25.23m (CNY180m) in a Series B financing round to support the development of its clinical-stage metabolic pipeline, in June 2023.
RESTRAINT: High cost of metabolism assay analyzers
The adoption of metabolism assays can be hindered due to the high costs, especially with limited budgeted facilities like smaller research laboratories or healthcare facilities. To mitigate these costs, the organizations may explore options like group purchasing, leasing or financing agreements, and collaborations with larger institutions. There is the development of more cost-effective analyzers or alternative testing methods that reduce expenses while maintaining accuracy and reliability, as technology advances and competition increases. For instance, the Seahorse Xfe 96 Cell Analyzer System and Seahorse XF HS Mini Analyzer by Agilent Technologies, Inc. (US) cost USD 189,612 and USD 68,611, respectively.
OPPORTUNITY: Integration with wearable devices
The overall health monitoring and management experience for individuals can be enhanced by integrating metabolism assay data with digital health platforms, apps, and wearable devices. For instance, Sweat-based wearable technologies have great potential to collect important data on biomarkers which are related to metabolic syndrome and its associated diseases. These wearable devices can measure glucose, CRP, cortisol, and sodium levels, making them invaluable for patients at risk of developing diabetes and cardiovascular diseases.
CHALLENGE: Complexity of assay development
Due to the intricate nature of metabolic pathways and the need for precise measurement techniques, it can be complex and time-consuming to develop accurate and reliable metabolism assays. Ensuring consistency and reproducibility across different experiments and laboratories can be a challenge. A multidisciplinary approach is required for these complexities which involves expertise in biochemistry, cell biology, molecular biology, analytical chemistry, and computational biology.
Metabolism Assays Market Ecosystem
Prominent companies in this market include well-established, financially stable manufacturers of metabolism assays. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, strong global sales and product portfolios, and marketing networks. Prominent companies in this market include Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), and Agilent Technologies Inc. (US).
In 2022, assay kits & reagents segment to observe the highest growth rate of the metabolism assays industry, by product.
Based on product, the metabolism assays market is classified into instruments & analyzers and assay kits & reagents. In 2022, the assay kits & reagents segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share can be attributed to features like availability and integration with other technologies like wearable devices.
In 2022, colorimetry segment to dominate the metabolism assays industry, by technology.
Based on technology, the metabolism assays market is segmented into colorimetry, fluorimetry, and spectrometry. The colorimetry segment accounted for the largest share of the market in 2022. Also, this segment is estimated to witness the highest growth during the forecast period. The large share is due to well-established method for measuring metabolites and biomarkers in a wide range of biological samples and large use in industrial settings to assess metabolic parameters and provide valuable data for various applications, including disease diagnosis and drug development.
In 2022, North America to dominate in metabolism assays industry.
The global metabolism assays market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate during the forecast period, primarily due to the sedentary work life which will lead to obesity & diabetes, and large population consuming junk food causing obesity. However, during the forecast period, Asia Pacific is expected to register highest CAGR. The factors contributing to the growth of Asia Pacific are large patient pool, growing number of local players, increasing awareness, and rise in disease research fundings by the government.
To know about the assumptions considered for the study, download the pdf brochure
The metabolism assays market is dominated by players such as Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), and Agilent Technologies Inc. (US).
Scope of the Metabolism Assays Industry:
|
Report Metric |
Details |
|
Market Revenue Size in 2023 |
$1.4 billion |
|
Projected Revenue Size by 2028 |
$2.1 billion |
|
Industry Growth Rate |
Poised to grow at a CAGR of 7.8% |
|
Market Driver |
Increasing funding and investments in metabolic research |
|
Market Opportunity |
Integration with wearable devices |
This research report categorizes the Metabolism assays market to forecast revenue and analyze trends in each of the following submarkets:
By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
By Product
- Instruments & Analyzers
- Assay Kits & Reagents
By Technology
- Colorimetry
- Fluorimetry
- Spectrometry
By Application
- Diagnostics
- Research
By End User
- Hospitals
- Diagnostics Laboratories
- Pharmaceutical & Biotechnology Companies and CROs & Academic Research Institutes
Recent Developments of Metabolism Assays Industry:
- In 2022, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) and Servier (France) for biopharmaceutical discovery and development laboratories.
- In 2021, Abcam Plc. (UK) acquired BioVision (UK). This acquisition of BioVision represents a compelling strategic fit for Abcam. This will bring greater control over the innovation and distribution of BioVision’s product portfolio and create value through portfolio expansion and leveraging Abcam’s global channels to market.
- In 2021, Agilent Technologies Inc. (US) launched Agilent Seahorse XF HS Miniplate which is the latest addition to Agilent’s range of Seahorse XF platforms, which analyze mitochondrial respiration, glycolysis, and ATP production in live cells, in real-time.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global metabolism assays market?
The global metabolism assays market boasts a total revenue value of $2.1 billion by 2028.
What is the estimated growth rate (CAGR) of the global metabolism assays market?
The global metabolism assays market has an estimated compound annual growth rate (CAGR) of 7.8% and a revenue size in the region of $1.4 billion in 2023.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the metabolism assays market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
Collecting Secondary Data
The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the metabolism assays market. A database of the key industry leaders was also prepared using secondary research.
Collecting Primary Data
The primary research data was conducted after acquiring knowledge about the metabolism assays market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as hospitals, clinics, fitness centers, home users, and academic & research institutes) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:
Breakdown of Primary Participants:
Note 1: *Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
All major product manufacturers offering various metabolism assays were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value metabolism assays market was also split into various segments and subsegments at the region and country level based on:
- Product mapping of various manufacturers for each type of metabolism assays market at the regional and country-level
- Relative adoption pattern of each metabolism assays market among key application segments at the regional and/or country-level
- Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
- Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level
Global Metabolism assays Market Size: Top Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Metabolism assays Market Size: Bottom-Up Approach.
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Metabolism assays industry.
Market Definition
Metabolic assay is used to identify metabolic stability in chemical structures in connection with hepatic metabolism. It evaluates the rate of clearance of a drug using the liver hepatocytes or microsomes. The disappearance of the parent chemical with time is an example of a change. Metabolism assay is available in comprehensive packages equipped with the essential components and detailed protocols required to investigate specific facets of cellular metabolism. These kits offer researchers a convenient and standardized approach to explore and understand metabolic processes accurately, efficiently, and consistently.
Key Stakeholders
- Senior Management
- Finance/Procurement Department
- Pathologist/Researchers/Technician
Report Objectives
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To define, describe, segment, and forecast the metabolism assays market by product, technology, application, end-user, and region
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall metabolism assay market
- To forecast the size of the metabolism assays market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Rest of the world.
- To profile key players in the metabolism assays market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the metabolism assays market.
- To benchmark players within the metabolism assays market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
MarketsandMarkets offers the following customizations for this market report:
Additional country-level analysis of the Metabolism assays market
Profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the Metabolism assays Market
Growth opportunities and latent adjacency in Metabolism Assays Market